194 related articles for article (PubMed ID: 24010642)
1. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
2. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
3. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
[TBL] [Abstract][Full Text] [Related]
5. [Association between APOBEC3G polymorphisms and susceptibility to chronic hepatitis B].
You Z; Zhou F; Wang X; Chen C; Zhou J; Zhao D; Hu G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):769-71. PubMed ID: 23689004
[TBL] [Abstract][Full Text] [Related]
6. [The associations between polymorphisms of APOBEC3G and different outcomes of persistent HBV infection].
Tian D; Zeng Z; Tian GB; Cui JJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):481-6. PubMed ID: 18647522
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
8. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S
J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716
[TBL] [Abstract][Full Text] [Related]
9. Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus.
Kanagaraj A; Sakamoto N; Que L; Li Y; Mohiuddin M; Koura M; Wakae K; Kurachi M; Muramatsu M; Kitamura K
Biochem Biophys Res Commun; 2019 Oct; 518(1):26-31. PubMed ID: 31400856
[TBL] [Abstract][Full Text] [Related]
10. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
12. Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals.
Rathore A; Chatterjee A; Yamamoto N; Dhole TN
Genet Test; 2008 Sep; 12(3):453-6. PubMed ID: 18652534
[TBL] [Abstract][Full Text] [Related]
13. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
Vartanian JP; Henry M; Marchio A; Suspène R; Aynaud MM; Guétard D; Cervantes-Gonzalez M; Battiston C; Mazzaferro V; Pineau P; Dejean A; Wain-Hobson S
PLoS Pathog; 2010 May; 6(5):e1000928. PubMed ID: 20523896
[TBL] [Abstract][Full Text] [Related]
14. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
Henry M; Guétard D; Suspène R; Rusniok C; Wain-Hobson S; Vartanian JP
PLoS One; 2009; 4(1):e4277. PubMed ID: 19169351
[TBL] [Abstract][Full Text] [Related]
15. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection.
Meier MA; Suslov A; Ketterer S; Heim MH; Wieland SF
J Viral Hepat; 2017 Aug; 24(8):662-671. PubMed ID: 28182305
[TBL] [Abstract][Full Text] [Related]
17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
18. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.
Zhang W; Zhang X; Tian C; Wang T; Sarkis PT; Fang Y; Zheng S; Yu XF; Xu R
Cell Microbiol; 2008 Jan; 10(1):112-21. PubMed ID: 17672864
[TBL] [Abstract][Full Text] [Related]
19. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
[TBL] [Abstract][Full Text] [Related]
20. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]